NASDAQ:PRLD

Prelude Therapeutics Stock Forecast

etoro logo Buy PRLD
*Your capital is at risk
$3.81
-0.270 (-6.62%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of PRLD AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PRLD to Watchlist?
Some Reasons Why To Add PRLD:
  • +269.9% price growth over the last year
  • High gross margin of 97.7%
  • Bullish trend confirmed on both short and long timeframes
PDF

A very red day for Prelude Therapeutics Incorporated stock price after a -6.62% fall in the Friday trading session
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 26, 2026 Loss -6.85%

The Prelude Therapeutics Incorporated stock price fell by -6.62% on the last day (Friday, 5th Jun 2026) from $4.08 to $3.81. During the last trading day the stock fluctuated 8.50% from a day low at $3.74 to a day high of $4.06. The price has fallen in 7 of the last 10 days and is down by -12.01% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -391 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.56 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 23.30% during the next 3 months and, with a 90% probability hold a price between $4.38 and $7.63 at the end of this 3-month period.

PRLD Signals & Forecast

There are few to no technical positive signals at the moment. The Prelude Therapeutics Incorporated stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.82 and $4.40. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -6.62%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Prelude Therapeutics Incorporated stock

Prelude Therapeutics Incorporated finds support from accumulated volume at $3.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.318 between high and low, or 8.50%. For the last week the stock has had daily average volatility of 9.46%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRLD) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Prelude Therapeutics Incorporated to open at $3.87, and during the day (based on 14 day Average True Range), to move between $3.61 and $4.01, which gives a possible trading interval of +/-$0.405 (+/-11.23%) up or down from last closing price. If Prelude Therapeutics Incorporated takes out the full calculated possible swing range there will be an estimated 11.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.68 (3.41%) than the resistance at $4.27 (12.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Prelude Therapeutics Incorporated stock A Buy?

The Prelude Therapeutics Incorporated stock holds several negative signals and despite the positive trend, we believe Prelude Therapeutics Incorporated will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.346 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $3.87 ( 1.59%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PRLD Performance

Trading levels for PRLD

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.19 9.94%
R2 4.07 6.75%
R1 3.99 4.78%
Price 3.81
S1 3.75 -1.60%
S2 3.67 -3.57%
S3 3.55 -6.76%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.70 23.36%
R2 4.40 15.49%
R1 4.27 12.07%
Price 3.81
S1 3.68 -3.41%
S2 3.66 -3.94%
S3 3.60 -5.51%

FAQ

What is the symbol for Prelude Therapeutics Incorporated Stock and on which exchange is it traded?
The symbol for Prelude Therapeutics Incorporated is PRLD and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Prelude Therapeutics Incorporated Stock?
The Prelude Therapeutics Incorporated stock holds several negative signals and despite the positive trend, we believe Prelude Therapeutics Incorporated will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Prelude Therapeutics Incorporated Stock?
Prelude Therapeutics Incorporated Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Prelude Therapeutics Incorporated Stock.

What's the current price of Prelude Therapeutics Incorporated Stock?
As of the end of day on the Jun 05, 2026, the price of an Prelude Therapeutics Incorporated (PRLD) share was $3.81.

What is the 52-week high and low for Prelude Therapeutics Incorporated Stock?
The 52-week high for Prelude Therapeutics Incorporated Stock is $5.54 and the 52-week low is $0.750.

What is the market capitalization of Prelude Therapeutics Incorporated Stock?
As of the Jun 05, 2026, the market capitalization of Prelude Therapeutics Incorporated is 216.914M.

When is the next earnings date for Prelude Therapeutics Incorporated?
The upcoming earnings date for Prelude Therapeutics Incorporated is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT PRELUDE THERAPEUTICS INCORPORATED
Prelude Therapeutics
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selecti...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE